Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Kees Hovingh"'
Autor:
Vallejo-Vaz AJ; School of Public Health, Imperial College London, London, UK.; Department of Medicine, Faculty of Medicine, University of Seville, Seville, Spain.; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/Universidad de Sevilla/CSIC, Seville, Spain., Bray S; Global Biostatistical Science, Amgen Ltd, Cambridge, UK., Villa G; Global Health Economics, Amgen Europe (GmbH), Rotkreuz, Switzerland., Brandts J; Imperial Centre for Cardiovascular Disease Prevention Imperial Clinical Trials Unit, Department of Primary Care and Public Health, School of Public Health, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.; Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany., Kiru G; Imperial Clinical Trials Unit, Imperial College London, London, UK., Murphy J; Imperial Clinical Trials Unit, Imperial College London, London, UK., Banach M; Department of Hypertension, Medical University of Łódź, Łódź, Poland.; Polish Mother's Memorial Hospital-Research Institute (PMMHRI), Łódź, Poland.; Cardiovascular Research Centre, University of Zielona Góra, Zielona Góra, Poland., De Servi S; IRCCS MultiMedica, Milan, Italy., Gaita D; Institutul de Boli Cardiovasculare, Fundatia Cardioprevent, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania., Gouni-Berthold I; Centre for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Kees Hovingh G; Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, Netherlands., Jozwiak JJ; Department of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Opole, Poland., Jukema JW; Leiden University Medical Center, Leiden, Netherlands., Gabor Kiss R; Hungarian Army Medical Center, Budapest, Hungary., Kownator S; Centre Cardiologique et Vasculaire, Thionville, France., Iversen HK; Department of Neurology, Stroke Centre Rigshospitalet, Copenhagen, Rigshospitalet, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Maher V; Trinity College Dublin, Dublin, Ireland.; Advanced Lipid Management and Research Centre, Tallaght University Hospital, Dublin, Ireland., Masana L; Universitat Rovira I Virgili, IISPV, CIBERDEM, Saint Joan University Hospital, Reus, Spain., Parkhomenko A; Emergency Cardiology Department, Institute of Cardiology, Kiev, Ukraine., Peeters A; Cliniques Universitaires Saint Luc, Brussels, Belgium., Clifford P; Imperial Hospitals NHS Trust (Hammersmith Campus), London, UK., Raslova K; Slovak Medical University, Bratislava, Slovakia., Siostrzonek P; Krankenhaus Barmherzige Schwestern Linz, Linz, Austria., Romeo S; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Clinical Nutrition, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.; Cardiology Department, Sahlgrenska University Hospital, Gothenburg, Sweden., Tousoulis D; National and Kapodistrian University of Athens, Medical School, Athens, Greece., Vlachopoulos C; National and Kapodistrian University of Athens, Medical School, Athens, Greece., Vrablik M; 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic., Catapano AL; IRCCS MultiMedica, Milan, Italy., Poulter NR; Imperial Clinical Trials Unit, Imperial College London, London, UK., Ray KK; Imperial Centre for Cardiovascular Disease Prevention Imperial Clinical Trials Unit, Department of Primary Care and Public Health, School of Public Health, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK. k.ray@imperial.ac.uk.; Imperial Clinical Trials Unit, Imperial College London, London, UK. k.ray@imperial.ac.uk.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2023 Oct; Vol. 37 (5), pp. 941-953. Date of Electronic Publication: 2022 May 14.
Autor:
Ursoniu S; Department of Functional Sciences, Discipline of Public Health, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania., Mikhailidis DP; Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK., Serban MC; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA; Department of Functional Sciences, Discipline of Pathophysiology, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania., Penson P; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK., Toth PP; Preventive Cardiology, CGH Medical Center, Sterling, Illinois, USA; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA., Ridker PM; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ray KK; Department of Primary Care and Public Health, School of Public Health, Imperial College London, UK., Kees Hovingh G; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Kastelein JJ; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands., Hernandez AV; Health Outcomes and Clinical Epidemiology Section, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; School of Medicine, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru., Manson JE; Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Rysz J; Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland., Banach M; Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland; Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. Electronic address: maciejbanach@aol.co.uk.
Publikováno v:
Pharmacological research [Pharmacol Res] 2017 Aug; Vol. 122, pp. 105-117. Date of Electronic Publication: 2017 Jun 09.
Autor:
Rosenson RS; Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, MC1 Level, New York, NY, 10029, USA. robert.rosenson@mssm.edu., Gandra SR; Amgen Inc., Thousand Oaks, CA, USA., McKendrick J; PRMA Consulting, Fleet, Hampshire, UK., Dent R; Amgen Inc., Thousand Oaks, CA, USA., Wieffer H; PRMA Consulting, Fleet, Hampshire, UK., Cheng LI; Amgen Inc., Thousand Oaks, CA, USA., Catapano AL; University of Milano and IRCCS Multimedica, Milan, Italy., Oh P; Toronto Rehabilitation Institute, Toronto, ON, Canada., Kees Hovingh G; Academic Medical Center, Amsterdam, the Netherlands., Stroes ES; Academic Medical Center, Amsterdam, the Netherlands.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2017 Apr; Vol. 31 (2), pp. 187-195.
Autor:
Serban C; Department of Functional Sciences, Discipline of Pathophysiology, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania., Sahebkar A; 1] Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran [2] Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia., Ursoniu S; Department of Functional Sciences, Chair of Public Health, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania., Mikhailidis DP; Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK., Rizzo M; Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Italy., Lip GY; University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK., Kees Hovingh G; Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands., Kastelein JJ; Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands., Kalinowski L; Department of Medical Laboratory Diagnostics, Medical University of Gdansk, Gdansk, Poland., Rysz J; Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland., Banach M; Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.
Publikováno v:
Scientific reports [Sci Rep] 2015 May 13; Vol. 5, pp. 9902. Date of Electronic Publication: 2015 May 13.
Autor:
Michalska-Kasiczak M; Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland., Sahebkar A; Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia., Mikhailidis DP; Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK., Rysz J; Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland., Muntner P; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA., Toth PP; Preventive Cardiology, CGH Medical Center, Sterling, IL, USA; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA., Jones SR; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA., Rizzo M; Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Italy., Kees Hovingh G; Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands., Farnier M; Department of Lipidology, Point Medical, Dijon, France., Moriarty PM; Department of Medicine, Schools of Pharmacy and Medicine, The University of Kansas Medical Center, KS City, USA., Bittner VA; Division of Cardiovascular Disease, Preventive Cardiology Section, University of Alabama at Birmingham, Birmingham, AL, USA., Lip GY; University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK., Banach M; Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland. Electronic address: maciejbanach@aol.co.uk.
Publikováno v:
International journal of cardiology [Int J Cardiol] 2015 Jan 15; Vol. 178, pp. 111-6. Date of Electronic Publication: 2014 Oct 22.
Autor:
Christina Reith, Colin Baigent, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies, Heather Halls, Lisa Holland, Kate Wilson, Jane Armitage, Charlie Harper, David Preiss, Alistair Roddick, Anthony Keech, John Simes, Rory Collins, Elizabeth Barnes, Jordan Fulcher, William G Herrington, Adrienne Kirby, Borislava Mihaylova, Rachel O'Connell, Pierre Amarenco, Philip Barter, D John Betteridge (deceased), Michael Blazing, Jackie Bosch, Louise Bowman, Eugene Braunwald, Christopher P Cannon, Michael Clearfield, Stuart Cobbe, Helen M Colhoun, Björn Dahlöf, Barry Davis, James de Lemos, John R Downs, Paul N Durrington, Bengt Fellström, Ian Ford, Maria Grazia Franzosi, John Fuller (deceased), Curt Furberg, Robert Glynn, David Gordon, Antonio Gotto Jr, Richard Grimm, Ajay Gupta, C Morton Hawkins, Graham A Hitman, Hallvard Holdaas (deceased), Alan Jardine, J Wouter Jukema, John JP Kastelein, Sharon Kean, John Kjekshus, Genell Knatterud (deceased), Robert H Knopp (deceased), Wolfgang Koenig, Michael Koren, Vera Krane, Martin Landray, John LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter Macfarlane, Stephen MacMahon, Aldo Maggioni, Roberto Marchioli, Ian Marschner, Lemuel Moyé, Sabina Murphy, Andrew Neil, Enrico B Nicolis, Chris Packard, Sarah Parish, Terje R Pedersen, Richard Peto, Marc Pfeffer, Neil Poulter, Sara Pressel, Jeffrey Probstfield, Mahboob Rahman, Paul M Ridker, Michele Robertson, Frank Sacks, Naveed Sattar, Roland Schmieder, Patrick W Serruys, Peter Sever, John Shaw (deceased), James Shepherd (deceased), Lara Simpson, Peter Sleight (deceased), Luigi Tavazzi, Gianni Tognoni, Andrew Tonkin, Stella Trompet, Christoph Wanner, Hans Wedel, Stephen Weis, K Michael Welch, Harvey White, John Wikstrand, Lars Wilhelmsen, Stephen Wiviott, Robin Young, Salim Yusuf, Faiez Zannad, Hiroyuki Arashi, Robert Byington, Robert Clarke, Marcus Flather, Uri Goldbourt, Shinya Goto, Jemma Hopewell, Kees Hovingh, Patricia Kearney, George Kitas, Connie Newman, Marc S Sabatine, Greg Schwartz, Liam Smeeth, Jonathan Tobert, John Varigos, Junichi Yamaguchi
Publikováno v:
The Lancet, 400(10355), 832-845. Elsevier Limited
Background: Statin therapy is effective for the prevention of atherosclerotic cardiovascular disease and is widely prescribed, but there are persisting concerns that statin therapy might frequently cause muscle pain or weakness. We aimed to address t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4616cab962081ebdd901d4a6e1652a20
https://pure.amc.nl/en/publications/effect-of-statin-therapy-on-muscle-symptoms(c31d56e2-803e-4f3b-881a-6f09bfa1f0f4).html
https://pure.amc.nl/en/publications/effect-of-statin-therapy-on-muscle-symptoms(c31d56e2-803e-4f3b-881a-6f09bfa1f0f4).html
Autor:
Henry N. Ginsberg, Neil J. Hounslow, Yusuke Senko, Hideki Suganami, Pawel Bogdanski, Richard Ceska, Akos Kalina, Roman A. Libis, Tatiana V. Supryadkina, G. Kees Hovingh
Publikováno v:
Diabetes care, 45(4), 898-908. American Diabetes Association Inc.
OBJECTIVE High plasma triglyceride (TG) is an independent risk factor for cardiovascular disease. Fibrates lower TG levels through peroxisome proliferator–activated receptor α (PPARα) agonism. Currently available fibrates, however, have relativel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f181e69a767b7adc7c8d8f4d2aa30c9
https://doi.org/10.2337/figshare.18028304
https://doi.org/10.2337/figshare.18028304
Autor:
Roeland Huijgen, G. Kees Hovingh, Erik S.G. Stroes, Laurens F. Reeskamp, Aldo Grefhorst, Tycho R Tromp
Publikováno v:
Atherosclerosis, 315, 68-75. Elsevier Ireland Ltd
Background and aims: Statins suppress hepatic mRNA expression of ANGPTL3 encoding angiopoietin-like 3 in healthy subjects, but it is unknown if plasma ANGPTL3 concentrations are affected by statins prescribed to hypercholesterolemic patients in clini
Autor:
Gaia Kiru, Neil R Poulter, Sarah Bray, Maciej Banach, Katarina Raslova, Alexander Parkhomenko, Dimitrios Tousoulis, Michal Vrablík, Charalambos Vlachopoulos, Helle K. Iversen, Serge Kownator, Róbert Gábor Kiss, Dan Gaita, Bart Molemans, Jacek Jerzy Jozwiak, André Peeters, Periklis Giovas, W. Marieke Schoonen, DA Vinci study, Luis Masana, Stefano De Servi, Piers Clifford, Vincent Maher, Ioanna Gouni-Berthold, Stefano Romeo, Alberico L. Catapano, J. Wouter Jukema, Peter Siostrzonek, G. Kees Hovingh, Jennifer Murphy, Kausik K. Ray
Publikováno v:
European Journal of Preventive Cardiology, 28(11), 1279-1289. OXFORD UNIV PRESS
European journal of preventive cardiology, 28(11), 1279-1289. SAGE Publications Ltd
European journal of preventive cardiology, Vol. 28, no. 11, p. 1279-1289 (2021)
Ray, K K & DA VINCI study 2021, ' EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care : the DA VINCI study ', European Journal of Preventive Cardiology, vol. 28, no. 11, pp. 1279–1289 . https://doi.org/10.1093/eurjpc/zwaa047
European journal of preventive cardiology, 28(11), 1279-1289. SAGE Publications Ltd
European journal of preventive cardiology, Vol. 28, no. 11, p. 1279-1289 (2021)
Ray, K K & DA VINCI study 2021, ' EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care : the DA VINCI study ', European Journal of Preventive Cardiology, vol. 28, no. 11, pp. 1279–1289 . https://doi.org/10.1093/eurjpc/zwaa047
Aims To provide contemporary data on the implementation of European guideline recommendations for lipid-lowering therapies (LLTs) across different settings and populations and how this impacts low-density lipoprotein cholesterol (LDL-C) goal achievem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a7f8dc611f9372ae51376e0a17cfab
http://hdl.handle.net/1887/3274109
http://hdl.handle.net/1887/3274109
Autor:
Robert M. Stoekenbroek, Norman E. Lepor, Frederick J. Raal, Peter L.J. Wijngaard, G. Kees Hovingh, David Kallend
Publikováno v:
Circulation, 141(22), 1829-1831. Lippincott Williams and Wilkins